Literature DB >> 20015290

The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytes.

Omar Janneh1, Andrew Owen, Patrick G Bray, David J Back, Munir Pirmohamed.   

Abstract

BACKGROUND AND
PURPOSE: Cultured pre-adipocytes accumulate and metabolize zidovudine (ZDV), but its mode of accumulation into these cells is unclear. We investigated the mode of accumulation of [(3)H]-ZDV, and the impact of changes in external pH and modulators of drug transporters on its accumulation and metabolism. EXPERIMENTAL APPROACH: The initial rate and steady-state accumulation of [(3)H]-ZDV were measured in 3T3-F442A cells. P-glycoprotein (P-gp) expression was detected by Western blotting. External pH was varied, and modulators of intracellular pH and drug transporters were used to study the mode of accumulation of ZDV. Phosphorylated ZDV metabolites were detected by high-performance liquid chromatography. KEY
RESULTS: Intracellular accumulation of ZDV was rapid, reaching equilibrium within 20 min; nigericin increased accumulation by 1.9-fold, but this did not alter the generation of ZDV mono-, di- and triphosphate. The accumulation and metabolism were pH dependent, being maximal at pH 7.4 and least at pH 5.1. Monensin, carbonyl cyanide p-trifluoromethoxy) phenyl hydrazone, brefeldin A, bafilomycin A1 and concanamycin A increased accumulation; 2-deoxyglucose, dipyridamole, thymidine and tetraphenylphosphonium inhibited accumulation. The accumulation was saturable; the derived K(d) and capacity of binding were 250 nmol per 10(6) cells and 265 nM respectively. 3T3-F442A cells express P-gp; inhibitors of P-gp (XR9576 and verapamil), P-gp/BCRP (GF120918), multidrug resistance protein (MRP) (MK571) and MRP/OATP (probenecid) increased the accumulation of ZDV. Saquinavir, ritonavir, amprenavir and lopinavir increased accumulation. CONCLUSIONS AND IMPLICATIONS: The accumulation of ZDV in 3T3-F442A cells was rapid, energy dependent, saturable and pH sensitive. Western blot analysis showed that 3T3-F442A cells express P-gp, and direct inhibition assays suggest that ZDV is a substrate of P-gp and MRP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015290      PMCID: PMC2825369          DOI: 10.1111/j.1476-5381.2009.00552.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  82 in total

1.  Inhibition of adipocyte differentiation by HIV protease inhibitors.

Authors:  B Zhang; K MacNaul; D Szalkowski; Z Li; J Berger; D E Moller
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 2.  Vacuolar and plasma membrane proton-adenosinetriphosphatases.

Authors:  N Nelson; W R Harvey
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

3.  Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture.

Authors:  M D Perloff; L L von Moltke; J M Fahey; J P Daily; D J Greenblatt
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

Review 4.  HIV-therapy associated lipodystrophy: experimental and clinical evidence for the pathogenesis and treatment.

Authors:  M V Stankov; G M N Behrens
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2007-12       Impact factor: 2.895

5.  Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.

Authors:  E V Batrakova; S Li; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

6.  Purification of the beta-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells.

Authors:  S Marshak; H Totary; E Cerasi; D Melloul
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 7.  The concentrative nucleoside transporter family, SLC28.

Authors:  Jennifer H Gray; Ryan P Owen; Kathleen M Giacomini
Journal:  Pflugers Arch       Date:  2003-07-11       Impact factor: 3.657

8.  MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells.

Authors:  Mark Eilers; Upal Roy; Debasis Mondal
Journal:  Exp Biol Med (Maywood)       Date:  2008-06-05

9.  Cloning and characterization of a vacuolar ATPase A subunit homologue from Plasmodium falciparum.

Authors:  S R Karcz; V R Herrmann; A F Cowman
Journal:  Mol Biochem Parasitol       Date:  1993-04       Impact factor: 1.759

10.  In vivo evaluation of P-glycoprotein and breast cancer resistance protein modulation in the brain using [(11)C]gefitinib.

Authors:  Kazunori Kawamura; Tomoteru Yamasaki; Joji Yui; Akiko Hatori; Fujiko Konno; Katsushi Kumata; Toshiaki Irie; Toshimitsu Fukumura; Kazutoshi Suzuki; Iwao Kanno; Ming-Rong Zhang
Journal:  Nucl Med Biol       Date:  2009-04       Impact factor: 2.408

View more
  4 in total

Review 1.  HIV Persistence in Adipose Tissue Reservoirs.

Authors:  Jacob Couturier; Dorothy E Lewis
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

2.  In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.

Authors:  Souzan B Yanni; Patrick F Augustijns; Daniel K Benjamin; Kim L R Brouwer; Dhiren R Thakker; Pieter P Annaert
Journal:  Drug Metab Dispos       Date:  2010-07-06       Impact factor: 3.922

3.  PharmGKB summary: zidovudine pathway.

Authors:  Yogita Ghodke; Peter L Anderson; Katrin Sangkuhl; Jatinder Lamba; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-12       Impact factor: 2.089

Review 4.  Specific Biological Features of Adipose Tissue, and Their Impact on HIV Persistence.

Authors:  Christine Bourgeois; Jennifer Gorwood; Aurélie Barrail-Tran; Claire Lagathu; Jacqueline Capeau; Delphine Desjardins; Roger Le Grand; Abderaouf Damouche; Véronique Béréziat; Olivier Lambotte
Journal:  Front Microbiol       Date:  2019-12-17       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.